SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-068228
Filing Date
2017-11-14
Accepted
2017-11-14 07:16:05
Documents
3
Period of Report
2017-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-26492_18k.htm 8-K 32012
2 EX-99.1 a17-26492_1ex99d1.htm EX-99.1 19857
3 GRAPHIC g264921mmi001.jpg GRAPHIC 3030
  Complete submission text file 0001104659-17-068228.txt   57298
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 171198302
SIC: 2834 Pharmaceutical Preparations